AKT1 and neuroblastoma: The activation of these enzymes increases the phosphorylation levels of oncogenic pathways of the kinases ERK1/2, AKT, and FAK, while their inhibition causes apoptosis, reduces cell migration, and increases the sensibility of NB cells to vincristine and cisplatin [249].